No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 12,534 | 8,037 | 11,351 | 8,185 | 8,978 | 10,949 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 3,810 | 1,239 | 1,651 | 580 | 695 | 768 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Winner Medical Co., Ltd., a subsidiary of Winner Group Limited, is a company dedicated to the entire lifecycle – from innovation and production to sales – of cotton-derived medical supplies and various consumer goods. Based in Shenzhen, China, its business primarily serves the Chinese market, yet its products reach customers in approximately 110 countries globally. The company's operations are distinctly segmented into Medical Consumables and Healthy Consumer Goods. Under the Medical Consumables umbrella, Winner Medical offers a comprehensive selection of wound care items, which include various gauze and non-woven dressings, bandages, complete dressing change kits, and advanced options like silicone and alginate dressings. This division also produces essential infection control products such as surgical kits, protective gowns, face masks, full-body protective clothing, isolation garments, gloves, and specialized footwear and headwear. Moreover, it supplies a range of disinfection and cleaning products, from cotton swabs, pads, and balls to alcohol wipes and general disinfectants. The Healthy Consumer Goods segment features its own line of non-woven fabric, alongside a broad array of finished non-woven consumer items like cotton facial tissues, wet wipes, feminine hygiene products, cotton buds, cosmetic pads, and disposable undergarments. This segment further extends to textile consumer products, offering everything from baby essentials and clothing to adult apparel and other fabric-based goods. These diverse product lines are marketed under the distinct brand names "Winner," "Purcotton," and "PureH2B." The company utilizes a multi-channel distribution strategy, engaging with pharmacy chains, hospitals, e-commerce platforms, and supermarkets to deliver its products. Winner Medical Co., Ltd. was founded in 1991.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Winner Medical Co., Ltd. (300888.SZ)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Winner Medical Co., Ltd., a subsidiary of Winner Group Limited, is a company dedicated to the entire lifecycle – from innovation and production to sales – of cotton-derived medical supplies and various consumer goods. Based in Shenzhen, China, its business primarily serves the Chinese market, yet its products reach customers in approximately 110 countries globally. The company's operations are distinctly segmented into Medical Consumables and Healthy Consumer Goods. Under the Medical Consumables umbrella, Winner Medical offers a comprehensive selection of wound care items, which include various gauze and non-woven dressings, bandages, complete dressing change kits, and advanced options like silicone and alginate dressings. This division also produces essential infection control products such as surgical kits, protective gowns, face masks, full-body protective clothing, isolation garments, gloves, and specialized footwear and headwear. Moreover, it supplies a range of disinfection and cleaning products, from cotton swabs, pads, and balls to alcohol wipes and general disinfectants. The Healthy Consumer Goods segment features its own line of non-woven fabric, alongside a broad array of finished non-woven consumer items like cotton facial tissues, wet wipes, feminine hygiene products, cotton buds, cosmetic pads, and disposable undergarments. This segment further extends to textile consumer products, offering everything from baby essentials and clothing to adult apparel and other fabric-based goods. These diverse product lines are marketed under the distinct brand names "Winner," "Purcotton," and "PureH2B." The company utilizes a multi-channel distribution strategy, engaging with pharmacy chains, hospitals, e-commerce platforms, and supermarkets to deliver its products. Winner Medical Co., Ltd. was founded in 1991.